LSBCF

LakeShore Biopharma Co., Ltd.

Healthcare · Biotechnology

$90.07 sample

+0.81 (+0.91%) 1D

Market cap

$311.5B

Price as of

2026-10-04

Latest filing

8-K · 2026-08-28

Alerts

8

Price$90.07 +5.73% 3M daily closessample

93.4884.07

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 23INSInsider sell: 10% owner
Sep 14INSInsider sell: EVP, Operations
Sep 07INSInsider sell: Director
Aug 28SEC8-K filed: material event
Aug 24INSInsider buy: Chief Executive Officer
Aug 13INSInsider sell: Chief Executive Officer
Aug 04INSInsider buy: Chief Financial Officer
Jul 29SECForm 144 filed

Sign up to see the real LSBCF record →

Company facts

SEC EDGAR registration

Name: LakeShore Biopharma Co., Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -25sample, -100 to +100
Reporting currency: USD

Who is positioning in LSBCF

sample

Insiders: 31 insider transactions over 90 days, net selling, $538.7M
Congress: 3 members traded over 90 days
Institutions · 13F: 9 funds hold $2.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$21.6B +21.7% y/y

Q4 2024Q3 2026

Inventory$12.4B +16.3% y/y

Q4 2024Q3 2026

Accounts receivable$9.7B +19.0% y/y

Q4 2024Q3 2026

Total debt$24.8B +11.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $217.4B +9.2% 3M
Sample peer B: $136.5B +9.2% 3M
Sample peer C: $39.1B +5.9% 3M
Sample peer D: $163.7B +3.4% 3M
Sample peer E: $91.6B +6.3% 3M